AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2014
May 19, 2014
35119_dirs_2014-05-19_12b7778c-553b-4591-85ea-11979afa867d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2014-05-19
Reporting Person: Warusz Joseph Michael (VP of Admin, Controller / PAO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-19 | Common Stock | M | 4690 | $0.64 | Acquired | 4690 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-19 | Option (Right to Buy) | $0.64 | M | 4690 | Disposed | 2021-11-30 | Common Stock (30000) | Direct |
Footnotes
F1: The option has vested as to 24,375 as of the date of this report, and vests as to the remainder of the shares on each of June 1, 2014, September 1, 2014 and December 1, 2014 at a rate of 1,875 shares. The exercise price of the option equals $0.64 per share, the market price of the Company's common stock as of the close of business on the date of grant. The shares numbers and prices have been adjusted for the reverse stock split of the Issuer's common stock at a ratio of 1-for-20 effective February 1, 2012.
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3